Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (201-210 of 645) with videos related to

Pageof 65
Sort By:
Journal of Experimental Pharmacology|December 16, 2020
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary DiseaseJosuel Ora, Angelo Coppola, Mario Cazzola, et al.
Expert Opinion on Therapeutic Targets|October 3, 2007
Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary diseaseMario Cazzola, Chiara Ciaprini, Clive P Page, et al.
Expert Opinion on Drug Delivery|June 21, 2023
Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPDRossella Laitano, Luigino Calzetta, Francesco Cavalli, et al.
Expert Opinion on Drug Safety|March 1, 2018
Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumabMario Cazzola, Maria Gabriella Matera, Francesca Levi-Schaffer, et al.
Journal of Clinical Medicine|August 12, 2022
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS ScorePaola Rogliani, Josuel Ora, Francesco Cavalli, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2013
β2-agonist therapy in lung diseaseMario Cazzola, Clive P Page, Paola Rogliani, et al.
Expert Opinion on Investigational Drugs|July 2, 2003
Therapeutic potential of the new quinolones in the treatment of lower respiratory tract infectionsFrancesco Blasi, Paolo Tarsia, Roberto Cosentini, et al.
Seminars in Oncology|September 28, 2011
Classification and prognostic evaluation of myelodysplastic syndromesMario Cazzola, Matteo G Della Porta, Erica Travaglino, et al.
Kardiologia Polska|February 5, 2023
Cardiovascular disease in asthma patients: From mechanisms to therapeutic implicationsMario Cazzola, Nicola A Hanania, Paola Rogliani, et al.
Expert Review of Respiratory Medicine|December 18, 2025
A review of the safety of antibody therapy in severe eosinophilic asthmaMaria Gabriella Matera, Vito De Novellis, Paola Rogliani, et al.
Pageof 65

Showing results (201-210 of 645) with videos related to

Sort By:
Pageof 65
Journal of Experimental Pharmacology|December 16, 2020
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary DiseaseJosuel Ora, Angelo Coppola, Mario Cazzola, et al.
Expert Opinion on Therapeutic Targets|October 3, 2007
Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary diseaseMario Cazzola, Chiara Ciaprini, Clive P Page, et al.
Expert Opinion on Drug Delivery|June 21, 2023
Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPDRossella Laitano, Luigino Calzetta, Francesco Cavalli, et al.
Expert Opinion on Drug Safety|March 1, 2018
Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumabMario Cazzola, Maria Gabriella Matera, Francesca Levi-Schaffer, et al.
Journal of Clinical Medicine|August 12, 2022
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS ScorePaola Rogliani, Josuel Ora, Francesco Cavalli, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2013
β2-agonist therapy in lung diseaseMario Cazzola, Clive P Page, Paola Rogliani, et al.
Expert Opinion on Investigational Drugs|July 2, 2003
Therapeutic potential of the new quinolones in the treatment of lower respiratory tract infectionsFrancesco Blasi, Paolo Tarsia, Roberto Cosentini, et al.
Seminars in Oncology|September 28, 2011
Classification and prognostic evaluation of myelodysplastic syndromesMario Cazzola, Matteo G Della Porta, Erica Travaglino, et al.
Kardiologia Polska|February 5, 2023
Cardiovascular disease in asthma patients: From mechanisms to therapeutic implicationsMario Cazzola, Nicola A Hanania, Paola Rogliani, et al.
Expert Review of Respiratory Medicine|December 18, 2025
A review of the safety of antibody therapy in severe eosinophilic asthmaMaria Gabriella Matera, Vito De Novellis, Paola Rogliani, et al.
Pageof 65